HomeVXL • CVE
add
Vaxil Bio Ltd
Previous close
$0.010
Year range
$0.0050 - $0.035
Market cap
1.37M CAD
Avg Volume
58.28K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | -31.00K | -117.92% |
Net income | 26.00K | 115.03% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 31.50K | 118.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 938.00K | -37.88% |
Total assets | 976.00K | -36.66% |
Total liabilities | 85.00K | -79.01% |
Total equity | 891.00K | — |
Shares outstanding | 136.98M | — |
Price to book | 1.00 | — |
Return on assets | 7.65% | — |
Return on capital | 8.85% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 26.00K | 115.03% |
Cash from operations | -69.00K | 62.30% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -71.00K | 59.43% |
Free cash flow | -76.62K | 31.66% |
About
Founded
2006
Headquarters
Website